Litigation Details for CAP-XX, Ltd. v. Maxwell Technologies, Inc. (D. Del. 2019)
✉ Email this page to a colleague
CAP-XX, Ltd. v. Maxwell Technologies, Inc. (D. Del. 2019)
Docket | ⤷ Try a Trial | Date Filed | 2019-09-16 |
Court | District Court, D. Delaware | Date Terminated | |
Cause | 35:1 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | Referred To | ||
Patents | 10,046,056; 6,555,542; 8,563,563 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in CAP-XX, Ltd. v. Maxwell Technologies, Inc.
Biologic Drugs cited in CAP-XX, Ltd. v. Maxwell Technologies, Inc.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for CAP-XX, Ltd. v. Maxwell Technologies, Inc. (D. Del. 2019)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2020-06-03 | 16 | Order - -Memorandum and Order | PageID #: 280 21-23, 42, 52-56, and 61-62 of the #034 patent, D.I. 10 ,r,r 19, 21, and claims 2, 6, …infringement of U.S. Patent Nos. 6,920,034 (the #034 patent) and 7,382,600 (the #600 patent). D.I. 10 at 4, 11. …products-for claim 13 of the #034 patent and claim 1 of the #600 patent. D.I. 10 ,r,r 21, 29. The above-mentioned… at least Claims 1 and 51 of the [#]034 patent." D.I. 10 ,r 19. CAP-XX makes the same allegations-with…#]034 Patent, . . . is equal to [the FOM value in the respective asserted claim]." D.I. 10 ,r,r | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |